APODEX PREDICTION
Evidence-Grounded Strategic Intelligence Solver
Apodex doesn't predict the future — it turns incomplete, conflicting, real-time information into evidence-grounded decisions.
All Apodex Predictions
Active Decision Domains
We choose high-stakes domains, continuously track a defined set of consequential questions, and update the evidence and probabilities as the world changes.
Biomedical & Pharma Intelligence
Evaluating high-stakes clinical trial endpoints, regulatory pathways, and drug pipeline trajectories. We cross-check molecular data, patent filings, and clinical trial registries to bypass market hype.
Clinical trial success probability mapping
Regulatory approval timeline tracking
Competitor pipeline risk assessment
Enterprise Tech & Competitive Strategy
Tracking competitor product releases, supply chain disruptions, and technology route transitions. We verify physical indicators, shipping lane bottlenecks, and patent filings to map market shifts.
Competitor product launch timelines
Supply chain bottleneck probability
Technology route adoption tracking
Investment & Risk Research
Providing intelligence support for macroeconomic policy shifts, central bank rate decisions, and geopolitical risk factors. We focus on verifiable data rather than speculative trading signals.
Central bank rate decision probability
Geopolitical risk exposure mapping
Macro policy transition tracking
The Decision Dossier
We don't publish a single confident-sounding number. Every report in every domain is structured as a continuously updated Decision Dossier:
Prediction + Key Drivers
The call, and the specific factors behind it
Will the Fed cut rates before Q3 2026?
What’s driving that view?
🏛 Fed guidance and minutes
💹 Market pricing
🏦 Major bank and forecaster views
📊 Macro data and risk balance
Competing Scenarios
Base case, upside, downside — not one story
Evidence Quality + Confidence
How strong the evidence is, not just the answer
Evidence
What's The Fed's Next Move? | J.P. Morgan Global Research
Strong
Will US Interest Rates Fall More in 2026? Our Latest Forecast
Strong
Powell's Swan Song: Fed Keeps Rates Unchanged - Charles Schwab
Strong
The Fed signals it will cut interest rates in 2026—and 3% is in sight
Strong
The Fed - Monetary Policy: - Federal Reserve
Medium
April 2026 Fed & Rates Call Update - MUFG Research
Medium
Change Triggers + Continuous Updates
What new evidence would flip the call, updated as it arrives
Trading Odds & Predictions
–45%
21.3%
vs last month
Fed Signals Shift With Markets Pricing
1.6X
23%
vs last month
A Dedicated Solver, Not a Bigger Model
Apodex is a Heavy-Duty Solver: it takes on hard, open-ended problems that have no existing answer, does the deep research to find one, and checks every step so the result can be trusted. Predictions is that same solver, dedicated to a narrower job — real-time, high-stakes forecasting.
Our strategic thesis: a general-purpose foundation model is not necessarily the best solver for a specific, open-ended real-world problem. A smaller model, paired with the right data, harness, evidence pipeline, and verifier, can outperform much larger models on that problem.
Predictions is where we make that thesis testable in public. Every domain on this page is a live, ongoing case where Apodex must gather fragmented, real-time, often conflicting information — before any ground truth exists — and turn it into a decision that holds up under scrutiny.
FutureX is our first proof point that a specialized solving system can outperform much larger general-purpose models on an open-ended, real-world problem — not proof that we are a general-purpose "Solver OS." That claim requires winning on a second, and a third, benchmark of a different nature.